Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06451874 · ClinicalTrials.gov registry record · NA
Personalized Exercise Treatments for Older Veterans With Motoric Cognitive Risk Syndrome
A NA study of Motoric Cognitive Risk Syndrome, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 54
- Enrollment target
- 1
- Study location
NCT06451874: Recruiting NA study of Motoric Cognitive Risk Syndrome, sponsored by VA Office of Research and Development.
NCT06451874 is a NA study of Motoric Cognitive Risk Syndrome that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 54 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06451874, a NA study of Motoric Cognitive Risk Syndrome, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will begin to evaluate personalized preventative dementia treatments for Veterans at risk for developing dementia. The investigators will target Veterans with Motoric Cognitive Risk syndrome (MCR), which is characterized by slow gait speed and cognitive concerns (e.g., problems with memory or concentrations).
Primary Outcome
Enrollment will be defined as the number of participants who were recruited and consented to the study.
Conditions Studied
Interventions
- BEHAVIORAL Functional Power Training (FPT)
- BEHAVIORAL Music-Based Digital Therapy (MBDT)
- BEHAVIORAL FPT + MBDT
Study Locations (1)
Massachusetts
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2025-07-01 |
| Est. Completion | 2029-12-31 |
| Phase | NA |
What NCT06451874 shows while recruiting
NCT06451874 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Motoric Cognitive Risk Syndrome appearing as the primary indexed condition, and to 3 interventions - of which Functional Power Training (FPT) is the first listed.
NCT06451874 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06451874 about?
NCT06451874 is a clinical study titled "Personalized Exercise Treatments for Older Veterans With Motoric Cognitive Risk Syndrome". This study will begin to evaluate personalized preventative dementia treatments for Veterans at risk for developing dementia. The investigators will target Veterans with Motoric Cognitive Risk syndrome (MCR), which is characterized by slow gait speed and cognitive concerns (e.g., problems with memor...
What is the current status of trial NCT06451874?
This trial is currently recruiting. It is a NA study. The enrollment target is 54 participants. The study started on 2025-07-01. Estimated completion is 2029-12-31.
What conditions does trial NCT06451874 study?
This clinical trial studies the following conditions: Motoric Cognitive Risk Syndrome.
What interventions are being tested in trial NCT06451874?
The interventions under investigation include: Functional Power Training (FPT) (BEHAVIORAL), Music-Based Digital Therapy (MBDT) (BEHAVIORAL), FPT + MBDT (BEHAVIORAL).
Who is sponsoring clinical trial NCT06451874?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06451874 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06451874's enrollment target sits among peer trials
54 1268th of 2000 higher than 730 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI